key: cord-0860267-fovjc2xc authors: Cotten, Matthew; Bugembe, Dan Lule; Kaleebu, Pontiano; Phan, My V T title: Alternate primers for whole-genome SARS-CoV-2 sequencing date: 2021-02-04 journal: Virus Evol DOI: 10.1093/ve/veab006 sha: ff6f117c6cdc31f11134829a11a0070548a37183 doc_id: 860267 cord_uid: fovjc2xc As the world is struggling to control the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), there is an urgency to develop effective control measures. Essential information is encoded in the virus genome sequence with accurate and complete SARS-CoV-2 sequences essential for tracking the movement and evolution of the virus and for guiding efforts to develop vaccines and antiviral drugs. While there is unprecedented SARS-CoV-2 sequencing efforts globally, approximately 19 to 43% of the genomes generated monthly are gapped, reducing their information content. The current study documents the genome gap frequencies and their positions in the currently available data and provides an alternative primer set and a sequencing scheme to help improve the quality and coverage of the genomes. Since the first report on 30 th December 2019 in Wuhan China and the WHO declaration of the pandemic on 12 th March 2020, the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (Edward C. Holmes, Yong-Zhen Zhang 2020) and the associated disease Coronavirus Disease 2019 (COVID-19) (Li et al. 2020 ) (Yang et al. 2020 ) have continued to spread throughout the world, causing >46 million infections and >1,200,000 death globally (Lauren Gardner et al. 2020) . The virus genome sequences carry important information, which can be used to interpret the virus transmission, evolution patterns and origin tracing. Furthermore, accurate and complete genomic sequences are essential for monitoring diagnostics and developing novel therapeutics and vaccines. We have seen an unprecedented amount of virus sequencing with over 130,000 complete or nearly complete genome sequences of SARS-CoV-2 now available in the GISAID database by the end of September 2020 (Shu and McCauley 2017) . Most of the sequences have been generated by next generation sequencing using targeted amplicon methods. A scan through SARS-CoV-2 genomes from GISAID with the filter "complete genome" revealed a high frequency of gaps occurring across the genome, influencing the overall genomics quality and interpretation. Here we describe an alternate primer scheme for whole-genome sequencing to improve the genome sequence quality and coverage. Documenting the problem https://mc.manuscriptcentral.com/vevolu We retrieved genomes deposited to GISAID in September 2020 (9 months into the pandemic), using the "complete genome" filter and sorting the genomes by sequencing platforms information included in the metadata. Figure 1 and nt 19,000-24,000 relative to the reference genome NC_045512), the patterns are not completely identical. Given the use of several primer amplification schemes, we suspect the gaps in coverage may be due to unexpected primer interactions, complicated sequence regions (odd composition or secondary structure), issues with primer trimming during quality control of read data, or some combinations of these factors. The phenomenon is unlikely to be due to an isolated set of genomes as we observed similar N200 frequencies in genomes submitted from each month of the pandemic ( Table 1 ), suggesting that gaps in coverage is a more general phenomenon. Of note, genomes generated using Ion Torrent show much lower levels of N200 ( Table 1 ). The very low https://mc.manuscriptcentral.com/vevolu frequency of large gaps in the Ion Torrent data may be due to the use of a dedicated alternative primer set (Alessandrini et al. 2020 ). There have been discussions and reports on the SARS-CoV-2 genome changes due to sequencing errors as well as long gaps in the genomes due to missing amplicons from the amplicon-approach sequencing (Nicola De Maio, Conor Walker, Rui Borges, Lukas Weilguny, Greg Slodkowicz, Nick Goldman 2020) (Page et al. 2020) . Updates of the ARTIC primers have been presented in late March 2020 to address these issues (Josh Quick and Nick Loman 2020) (Tyson et al. 2020) . Additional reports of longer amplicon methods have been published (Freed et al. 2020 ) (Eden et al. 2020 ) (Gonzalez-Reiche et al. 2020) including methods to use a subset of ARTIC primers to generate longer amplicons (Itokawa et al. 2020 ). However, the percentage of reported complete genomes in GISAID with 1 or more N200s continues, with 10,611 (28%) of the 38,228 genomes deposited in September 2020 having 1 or more N200 gaps (Table 1) , indicating the challenges remain largely unsolved. A more focused analysis of the frequent gaps is provided in Figure 2 We explored an alternate set of amplification primers (termed the Entebbe primers) designed using methods we had previously used for MERS-CoV (Matthew Cotten et al. 2013 ), Norovirus (M. Cotten et al. 2014) , RSV (Agoti et al. 2015) and Yellow Fever virus (Phan et al. 2019) . Important for the design were the amplicon size and the primer https://mc.manuscriptcentral.com/vevolu placement. For their implementation, the use of primers for the reverse transcription step, and the multiplexing of the amplicons in two staggered sets was important for the PCR. Our experience had suggested an optimum amplicon size of around 1500 bp. The larger amplicons reduced the total primers content of the reactions but still allowed high reverse transcription efficiency (which, in our hands, declined beyond 1500 nt). Here we describe primers designed for whole-genome sequencing of SARS-CoV-2, as well as sharing the detailed laboratory methods that we used for reverse transcription, PCR amplification and MinION library preparation to successfully sequence the SARS-CoV-2 genome. Briefly, the primer design ( Figure 3A ) started with the set of complete SARS-CoV-2 genome sequences available in the GISAID database on 22 June 2020 (N = 21,687). Spaces and disruptive characters were removed from the sequence IDs and the sequences were further screened to remove genomes containing gaps of 6Ns or more, resulting in 17,220 clean genome sequences. Next, all sequences were sliced into 33nt strings (33mers), with a 1nt step and 606,389 unique 33mers were generated. The frequency of each 33mer was counted to identify highly conserved 33mers. This counting method avoids the multiple sequence alignment step commonly used in primer design and becomes prohibitive with large and or diverse genome sets. This alignment-free approach allowed us to use all suitable genome sequences of interest rather than a set that could be conveniently 8 aligned. Finally, primer-like 33mers sequences were generated by trimming the sequences to a calculated desired melting temperature and removing any primers greater than 26nt. In the second step we defined forward and reverse primer target regions (bins) for the amplicons. For SARS-CoV-2, we selected 20 amplicons with an overlap of 300nt, regularly spaced across the SARS-CoV-2 genome sequence ( Figure 3B ). We then selected the top conserved primer sequences (the highest frequency primers) mapping in the 5' or 3' 185nt of each amplicon. For security, the two highest frequency primers per bin were selected for the SARS-CoV-2 sequence, this provided some insurance against primer failure either due to target evolution or unexpected secondary structure. The binning and primer target locations for the final set of primers are shown in Figure 2 and the final calculated amplicon lengths were 1495-2093nt. The reverse transcription, PCR amplification and library protocols were modified to accommodate the new primers. Important changes to note are the following. Reverse transcription was performed using the reverse primers and reverse transcription at 42°C. The PCR cycling conditions (using Phusion enzyme) were adjusted for the new T m s and an increased elongation time required for the longer PCR products. Finally, the library purification steps were adjusted to recover longer PCR and library products. A detailed stepby-step protocol is provided in the supplementary material. 9 We tested the Entebbe primers performance for sequencing SARS-CoV-2 from Given the urgency of controlling the SARS-CoV-2 pandemic and the importance of having good quality SARS-CoV-2 genomes, we are providing these alternative primers (the Entebbe primers) with detailed step-by-step laboratory protocols to the community with the hope that they benefit from the new design. The costs and efforts of sequencing SARS-CoV-2 in the large case numbers that are currently being seen are substantial and if these new primers result in a higher proportion of gap-less genomes, this will provide added value and will increase the utility of the resulting data. Local Evolutionary Patterns of Human Respiratory Syncytial Virus Derived from Whole-Genome Sequencing Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing Deep Sequencing of Norovirus Genomes Defines Evolutionary Patterns in an Urban Tropical Setting Full-Genome Deep Sequencing and Phylogenetic Analysis of Novel Human Betacoronavirus Linked to Returned Travellers from Iran Initial Genome Release of Novel Coronavirus Rapid and Inexpensive Whole-Genome Sequencing of SARS-CoV-2 Using 1200 Bp Tiled Amplicons and Oxford Nanopore Rapid Barcoding Introductions and Early Spread of SARS-CoV-2 in the New York City Area Disentangling Primer Interactions Improves SARS-CoV-2 Genome Sequencing by Multiplex Tiling PCR NCoV-2019 Version 3 Amplicon Releas Coronavirus COVID-19 Global Cases by Johns Hopkins CSSE Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia Issues with SARS-CoV-2 Sequencing Data Large Scale Sequencing of SARS-CoV-2 Genomes from One Region Allows Detailed Epidemiology and Enables Local Outbreak Management Genomic Sequence of Yellow Fever Virus from a Dutch Traveller Returning from the Gambia-Senegal Region, the GISAID: Global Initiative on Sharing All Influenza Data -from Vision to Reality Improvements to the ARTIC Multiplex PCR Method for SARS-CoV-2 Genome Sequencing Using Nanopore China: A Single-Centered, Retrospective Number of genomes with the annotation "complete Genomes were sorted by the presence or absence of the sequence N200 Number of genomes in GISAID for this period generated using any of the Illumina methods as noted in the GISAID "Sequencing technology metadata Number of genomes in GISAID for this period generated using any of the Ion Torrent methods as noted in the GISAID "Sequencing technology metadata" and their percentage. 10.,11. Number of genomes in GISAID for this period generated using unclear methods as noted in the GISAID "Sequencing technology metadata We thank all global SARS-CoV-2 sequencing groups for their open and rapid sharing of sequence data and GISAID for providing an effective platform for making these data available. We are grateful to the Oxford Nanopore Technologies and the ARTIC Network for their support with protocols and analysis software. We thank the Central Public Health Laboratory, Uganda especially Isaac Ssewanyana, Patrick Semanda, Susan N. Nabadda for their support with SARS-CoV-2 samples.We acknowledge the support of the Uganda Ministry of Health and its COVID-19Scientific Advisory Committee, the National COVID-19 Task Force, and the staff of the Emerging and Remerging Infections Department of the Uganda Virus Research Institute, https://mc.manuscriptcentral.com/vevolu -31Jan20 54 1 2 9 0 2 0 0 0 43 2 1Feb20-29Feb20 126 2 2 44 0 9 0 5 0 65 4 1Mar20-31Mar20 2872 559 19 1518 16 548 32 35 6 771 18 1Apr20-30Apr20 12411 3745 30 4970 38 1286 27 264 0 5424 26 1May20-31May20 19787 8606 43 8634 52 2634 30 529 0 7990 42 1Jun20-30Jun20 21665 8723 40 7043 36 3844 35 629 2 10149 47 1Jul20-31Jul20 17986 4834 27 4965 23 1585 33 471 2 10965 29 1Aug20-31Aug20 17276 4005 23 11074 22 2270 26 486 0 3446 28 1Sep20-30Sep20 38227 10611 28 22740 23 7973 44 580 1 6934